Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.

@article{Clift1994MarrowTF,
  title={Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.},
  author={Reginald A. Clift and C. Dean Buckner and E. Donnall Thomas and Eileen Bryant and Claudio Anasetti and William Ira Bensinger and Rebecca Bowden and H. Joachim Deeg and Kristine C Doney and Lloyd D Fisher},
  journal={Blood},
  year={1994},
  volume={84 12},
  pages={4368-73}
}
The records were reviewed of 58 patients receiving transplants in Seattle with unmanipulated marrow from HLA-identical siblings during the accelerated phase (AP) of chronic myeloid leukemia. Variables examined for association with survival and relapse included the interval from diagnosis to transplant, the reasons for categorization as AP, age, regimen, and cytomegalovirus serology. Four patients relapsed. The 4-year probabilities of survival, relapse-free survival, nonrelapse mortality, and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Allogeneic transplant for chronic myeloid leukemia in 2010.

Therapeutic advances in hematology • 2010
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Use of interferon alfa2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation

CS Higano, WH Raskind, J WSinger
Acta Haematol • 1993

Clinical bone marrow transplantation: Donor selection and recipient

JA Hansen, EM Mickelson, +4 authors ED Thomas
American Society for Microbiology, • 1992

Similar Papers

Loading similar papers…